HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Jira, P. E. Articles by Wevers, R. A. Search for Related Content PubMed PubMed Citation Articles by Jira, P. E. Articles by Wevers, R. A. Related Collections Molecular Diagnostics and Genetics Lipids, Lipoproteins, and Cardiovascular Risk Factors

Pitfalls in measuring plasma cholesterol in the Smith–Lemli–Opitz syndrome

Institutes of ¹ Pediatrics and ² Neurology, University Hospital Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
^a Author for correspondence. Fax +31.24.3540297; e-mail r.wevers{at}ckslkn.azn.nl

Correct quantitative results for plasma cholesterol, 7-dehydrocholesterol (7-DHC), and 8-dehydrocholesterol (8-DHC) are invaluable for making the correct diagnosis in patients with the Smith–Lemli–Opitz syndrome (SLO) and for biochemical monitoring of these patients during therapy. The enzymatic method for cholesterol measurement based on cholesterol oxidase gives falsely high values for plasma cholesterol in samples from patients with SLO. Both 7-DHC and 8-DHC contribute substantially to the test result, given that they are accepted substrates of cholesterol oxidase. All cholesterol methods making use of this enzyme are expected to give unreliable results with plasma samples from SLO patients. Cholesterol values found with these methods may be low-normal in individual cases with SLO. Therefore, other techniques for measuring cholesterol, 7-DHC, and 8-DHC, e.g., gas chromatography, should be used for diagnosing these patients and for follow-up during therapy. However, a normal value for plasma cholesterol, as obtained by gas chromatography, does not exclude SLO. The diagnosis should always be confirmed or excluded by testing for the presence of high concentrations of 7-DHC and 8-DHC in plasma. We found that one patient with a severe form of the disease had a plasma cholesterol concentration of 20 µmol/L—to our knowledge, the lowest value ever recorded in a human being.

Key Words: indexing terms: cholesterol oxidase • inborn errors of metabolism • gas chromatography • dehydrocholesterol • enzymatic assays • analytical error

The following articles in journals at HighWire Press have cited this article:

				A. Honda, K. Yamashita, H. Miyazaki, M. Shirai, T. Ikegami, G. Xu, M. Numazawa, T. Hara, and Y. Matsuzaki Highly sensitive analysis of sterol profiles in human serum by LC-ESI-MS/MS J. Lipid Res., September 1, 2008; 49(9): 2063 - 2073. [Abstract] [Full Text] [PDF]

				M. Valenza, J. B. Carroll, V. Leoni, L. N. Bertram, I. Bjorkhem, R. R. Singaraja, S. Di Donato, D. Lutjohann, M. R. Hayden, and E. Cattaneo Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation Hum. Mol. Genet., September 15, 2007; 16(18): 2187 - 2198. [Abstract] [Full Text] [PDF]

				M. Oostendorp, U. F.H. Engelke, M. A.A.P. Willemsen, and R. A. Wevers Diagnosing Inborn Errors of Lipid Metabolism with Proton Nuclear Magnetic Resonance Spectroscopy Clin. Chem., July 1, 2006; 52(7): 1395 - 1405. [Abstract] [Full Text] [PDF]

				P. E. Jira, R. A. Wevers, J. de Jong, E. Rubio-Gozalbo, F. S. M. Janssen-Zijlstra, A. F. J. van Heyst, R. C. A. Sengers, and J. A. M. Smeitink Simvastatin: a new therapeutic approach for Smith-Lemli-Opitz syndrome J. Lipid Res., August 1, 2000; 41(8): 1339 - 1346. [Abstract] [Full Text]